Item 2.02 Results of Operations and Financial Condition.
On November 10, 2021, Tempest Therapeutics, Inc. (the "Company") issued a press
release announcing its financial results for the third fiscal quarter ended
September 30, 2021. A copy of the Company's press release dated November 10,
2021, titled "Tempest Reports Third Quarter 2021 Financial Results and Provides
Corporate Highlights" is attached hereto as Exhibit 99.1 and is incorporated
herein by reference.
The foregoing information (including the exhibit hereto) is being furnished
under "Item 2.02 Results of Operations and Financial Condition" and shall not be
deemed "filed" for purposes of Section 18 of the Securities Exchange Act of
1934, as amended, nor shall it be deemed incorporated by reference in any filing
under the Securities Act of 1933, as amended, except as shall be expressly set
forth by specific reference in such filing.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.

Exhibit No.       Description


99.1                Press release dated November 10, 2021

104               Cover Page Interactive Data File (embedded within the Inline XBRL document)



--------------------------------------------------------------------------------

© Edgar Online, source Glimpses